Alpha interferon-induced antiviral response noncytolytically reduces replication defective adenovirus DNA in MDBK cells

Antiviral Research

Volumn 76, Issue 3, 2007, Pages 232-240

  Guo, Ju Tao ^a   Zhou, Tianlun ^b   Guo, Haitao ^a   Block, Timothy M ^a,b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b HEPATITIS B FOUNDATION   (United States)

Author keywords

Adenovirus; Hepatitis B; Interferon; Vectors

Indexed keywords

ADENOVIRUS VECTOR; ALPHA INTERFERON; CELL DNA; GREEN FLUORESCENT PROTEIN;

ADENOVIRUS; ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CELL LINE; COW; DNA REPLICATION; DNA VIRUS; DRUG INHIBITION; HEPATITIS B; HOST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INFECTION; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; CATTLE; CELL LINE; CELL NUCLEUS; DNA, VIRAL; GENETIC VECTORS; HEPATITIS B VIRUS; INTERFERON-ALPHA; RNA, VIRAL; VIRUS REPLICATION;

ADENOVIRIDAE; BOVINAE; DNA VIRUSES; HEPATITIS B VIRUS;

EID: 35348969739     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2007.06.015     Document Type: Article

References (38)

1. Angeletti P.C., and Engler J.A. Adenovirus preterminal protein binds to the CAD enzyme at active sites of viral DNA replication on the nuclear matrix. J. Virol. 72 4 (1998) 2896-2904
2. Aurisicchio L., De Tomassi A., La Monica N., Ciliberto G., Traboni C., and Palombo F. Regulated and liver-specific tamarin alpha interferon gene delivery by a helper-dependent adenoviral vector. J. Virol. 79 11 (2005) 6772-6780
3. Demers G.W., Sugarman B.J., Beltran J.C., Westreich L.N., Ahmed C.M., Lau J.Y., Hong Z., Lanford R.E., and Maneval D.C. Interferon-alpha2b secretion by adenovirus-mediated gene delivery in rat, rabbit, and chimpanzee results in similar pharmacokinetic profiles. Toxicol. Appl. Pharmacol. 180 1 (2002) 36-42
4. Doucas V., Ishov A.M., Romo A., Juguilon H., Weitzman M.D., Evans R.M., and Maul G.G. Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev. 10 2 (1996) 196-207
5. Fallows D.A., and Goff S.P. Mutations in the epsilon sequences of human hepatitis B virus affect both RNA encapsidation and reverse transcription. J. Virol. 69 5 (1995) 3067-3073
6. Fredman J.N., and Engler J.A. Adenovirus precursor to terminal protein interacts with the nuclear matrix in vivo and in vitro. J. Virol. 67 6 (1993) 3384-3395
7. Gish R.G. Clinical trial results of new therapies for HBV: implications for treatment guidelines. Semin. Liver Dis. 25 1 (2005) 29-39
8. Guidotti L.G., Rochford R., Chung J., Shapiro M., Purcell R., and Chisari F.V. Viral clearance without destruction of infected cells during acute HBV infection [in process citation]. Science 284 5415 (1999) 825-829
9. Guidotti L.G., Morris A., Mendez H., Koch R., Silverman R.H., Williams B.R., and Chisari F.V. Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice. J. Virol. 76 6 (2002) 2617-2621
10. Guo J.T., Bichko V.V., and Seeger C. Effect of alpha interferon on the hepatitis C virus replicon. J. Virol. 75 18 (2001) 8516-8523
11. Hayashi Y., and Koike K. Interferon inhibits hepatitis B virus replication in a stable expression system of transfected viral DNA. J. Virol. 63 7 (1989) 2936-2940
12. He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., and Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. U.S.A. 95 5 (1998) 2509-2514
13. Janssen H.L., van Zonneveld M., Senturk H., Zeuzem S., Akarca U.S., Cakaloglu Y., Simon C., So T.M., Gerken G., de Man R.A., Niesters H.G., Zondervan P., Hansen B., and Schalm S.W. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial. Lancet 365 9454 (2005) 123-129
14. Joseph T.D., and Look D.C. Specific inhibition of interferon signal transduction pathways by adenoviral infection. J. Biol. Chem. 276 50 (2001) 47136-47142
15. Kafri T., Morgan D., Krahl T., Sarvetnick N., Sherman L., and Verma I. Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy. Proc. Natl. Acad. Sci. U.S.A. 95 19 (1998) 11377-11382
16. Kajon A.E., and Spindler K.R. Mouse adenovirus type 1 replication in vitro is resistant to interferon. Virology 274 1 (2000) 213-219
17. Keskinen P., Nyqvist M., Sareneva T., Pirhonen J., Melen K., and Julkunen I. Impaired antiviral response in human hepatoma cells. Virology 263 2 (1999) 364-375
18. Ladner S.K., Otto M.J., Barker C.S., Zaifert K., Wang G.H., Guo J.T., Seeger C., and King R.W. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob. Agents Chemother. 41 8 (1997) 1715-1720
19. Lau G.K., Piratvisuth T., Luo K.X., Marcellin P., Thongsawat S., Cooksley G., Gane E., Fried M.W., Chow W.C., Paik S.W., Chang W.Y., Berg T., Flisiak R., McCloud P., and Pluck N. Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B. N. Engl. J. Med. 352 26 (2005) 2682-2695
20. Lieber A., He C.Y., and Kay M.A. Adenoviral preterminal protein stabilizes mini-adenoviral genomes in vitro and in vivo. Nat. Biotechnol. 15 13 (1997) 1383-1387
21. Nelson J.E., and Kay M.A. Persistence of recombinant adenovirus in vivo is not dependent on vector DNA replication. J. Virol. 71 11 (1997) 8902-8907
22. Otake K., Ennist D.L., Harrod K., and Trapnell B.C. Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responses. Hum. Gene Ther. 9 15 (1998) 2207-2222
23. Reich N., Pine R., Levy D., and Darnell Jr. J.E. Transcription of interferon-stimulated genes is induced by adenovirus particles but is suppressed by E1A gene products. J. Virol. 62 1 (1988) 114-119
24. Reichel P.A., Merrick W.C., Siekierka J., and Mathews M.B. Regulation of a protein synthesis initiation factor by adenovirus virus-associated RNA. Nature 313 5999 (1985) 196-200
25. Schaack J., Ho W.Y., Freimuth P., and Shenk T. Adenovirus terminal protein mediates both nuclear matrix association and efficient transcription of adenovirus DNA. Genes Dev. 4 7 (1990) 1197-1208
26. Schlaak J.F., Hilkens C.M., Costa-Pereira A.P., Strobl B., Aberger F., Frischauf A.M., and Kerr I.M. Cell-type and donor-specific transcriptional responses to interferon-alpha. Use of customized gene arrays. J. Biol. Chem. 277 51 (2002) 49428-49437
27. Seeger C., and Mason W.S. Hepatitis B virus biology. Microbiol. Mol. Biol. Rev. 64 1 (2000) 51-68
28. Sen G.C. Viruses and interferons. Annu. Rev. Microbiol. 55 (2001) 255-281
29. Shin E.C., Protzer U., Untergasser A., Feinstone S.M., Rice C.M., Hasselschwert D., and Rehermann B. Liver-directed gamma interferon gene delivery in chronic hepatitis C. J. Virol. 79 21 (2005) 13412-13420
30. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., and Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 67 (1998) 227-264
31. Stetson D.B., and Medzhitov R. Type I interferons in host defense. Immunity 25 3 (2006) 373-381
32. Sung R.S., Qin L., and Bromberg J.S. TNFalpha and IFNgamma induced by innate anti-adenoviral immune responses inhibit adenovirus-mediated transgene expression. Mol. Ther. 3 5 Pt 1 (2001) 757-767
33. Suzuki K., Aoki K., Ohnami S., Yoshida K., Kazui T., Kato N., Inoue K., Kohara M., and Yoshida T. Adenovirus-mediated gene transfer of interferon alpha inhibits hepatitis C virus replication in hepatocytes. Biochem. Biophys. Res. Commun. 307 4 (2003) 814-819
34. Tur-Kaspa R., Teicher L., Laub O., Itin A., Dagan D., Bloom B.R., and Shafritz D.A. Alpha interferon suppresses hepatitis B virus enhancer activity and reduces viral gene transcription. J. Virol. 64 4 (1990) 1821-1824
35. Wieland S.F., Spangenberg H.C., Thimme R., Purcell R.H., and Chisari F.V. Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees. Proc. Natl. Acad. Sci. U.S.A. 101 7 (2004) 2129-2134
36. Wu Q., Brum M.C., Caron L., Koster M., and Grubman M.J. Adenovirus-mediated type I interferon expression delays and reduces disease signs in cattle challenged with foot-and-mouth disease virus. J. Interferon Cytokine Res. 23 7 (2003) 359-368
37. Wursthorn K., Lutgehetmann M., Dandri M., Volz T., Buggisch P., Zollner B., Longerich T., Schirmacher P., Metzler F., Zankel M., Fischer C., Currie G., Brosgart C., and Petersen J. Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B. Hepatology 44 3 (2006) 675-684
38. Zhou T., Guo H., Guo J.T., Cuconati A., Mehta A., and Block T.M. Hepatitis B virus e antigen production is dependent upon covalently closed circular (ccc) DNA in HepAD38 cell cultures and may serve as a cccDNA surrogate in antiviral screening assays. Antiviral Res. 72 2 (2006) 116-124